Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis
Caocci, Giovanni
First
;Mulas, OlgaSecond
;Costa, Alessandro;Barabino, Luca;Greco, Marianna;La Nasa, GiorgioLast
2022-01-01
File | Size | Format | |
---|---|---|---|
Ruxolitinib does not impair humoral immune response to COVID‐19 vaccination with BNT162b2 mRNA COVID‐19 vaccine in patients with myelofibrosis.pdf Solo gestori archivio
Type: versione editoriale
Size 369.24 kB
Format Adobe PDF
|
369.24 kB | Adobe PDF | & nbsp; View / Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.